ALPS Advisors’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $293K | Sell |
|
|||||
|
2025
Q1 | $303K | Sell |
|
|||||
|
2024
Q4 | $519K | Buy |
|
|||||
|
2024
Q3 | $1.62M | Sell |
|
|||||
|
2024
Q2 | $1.29M | Buy |
|
|||||
|
2024
Q1 | $1.68M | Buy |
|
|||||
|
2023
Q4 | $780K | Sell |
|
|||||
|
2023
Q3 | $698K | Buy |
|
|||||
|
2023
Q2 | $874K | Buy |
|
|||||
|
2023
Q1 | $803K | Buy |
|
|||||
|
2022
Q4 | $897K | Buy |
|
|||||
|
2022
Q3 | $528K | Sell |
|
|||||
|
2022
Q2 | $394K | Sell |
|
|||||
|
2022
Q1 | $1.34M | Sell |
|
|||||
|
2021
Q4 | $1.58M | Sell |
|
|||||
|
2021
Q3 | $1.13M | Sell |
|
|||||
|
2021
Q2 | $1.3M | Buy |
|